Cognate BioServices, Inc. was formed to provide full commercialization support to companies developing varied cellular technologies, encountering translational challenges in development, manufacturing, quality, regulatory and delivery. The expertise of the management team and staff provides a cost-effective solution to the need in the current market for early focus on product development and clinical phase planning, without the need for extensive capital outlay.
Our goal is to support client efforts to bring their cell-based and regenerative medicine products to the clinic. Cognate has a fully integrated company with highly experienced technical staff and management team, along with a fully validated cGMP Manufacturing facility and state of the art research and development laboratories. Cognate also has the ability to rapidly advance technology from early research stages through pre-clinical & process development, GMP manufacturing and scale-up, regulatory submission to the clinic. Cognate offers a broad range of methods development and testing services for cell-based products and cell-based assays. Our laboratory experts understand assay development for early product research, process development, and cGMP in-process and release testing. Cognate's preclinical team works with client developers to support planning, performance, and analysis of preclinical studies. The expertise of the process development team provides a cost-effective solution for product development and clinical phase planning. – less – More from ZoomInfo »